A clear preponderance of smokers and alcohol drinkers among UADT cases compared with controls was observed.
Cancers of the upper aerodigestive tract (UADT) include those of the oral cavity, pharynx (other than nasopharynx), larynx, and esophagus. Tobacco smoking and consumption of alcoholic beverages are established causes of UADT cancers, whereas reduced intake of vegetables and fruits are likely causes. The role of genetic predisposition and possible interactions of genetic with exogenous factors, however, have not been adequately studied. Moreover, the role of pattern of smoking and drinking, as well as the exact nature of the implicated dietary variables, has not been clarified. To address these issues, the International Agency for Research on Cancer initiated in 2002 the alcohol-related cancers and genetic susceptibility (ARCAGE) in Europe project, with the participation of 15 centers in 11 European countries. Information and biological data from a total of 2304 cases and 2227 controls have been collected and will be used in a series of analyses. A total of 166 single nucleotide polymorphisms of 76 genes are being studied for genetic associations with UADT cancers. We report here the methodology of the ARCAGE project, main demographic and lifestyle characteristics of the cases and controls, as well as the distribution of cases by histology and subsite. About 80% of cases were males and fewer than 20% of all cases occurred before the age of 50 years. Overall, the most common subsite was larynx, followed by oral cavity, oropharynx, esophagus and hypopharynx. Close to 90% of UADT cancers were squamous cell carcinomas.
Introduction
Cancers of the upper aerodigestive tract (UADT) include those of the oral cavity, pharynx other than nasopharynx, larynx, and esophagus. In the 27-member state European Union, UADT cancers are responsible, as a group, for approximately 180 000 new cases per year, causing close to 110 000 deaths (Ferlay et al., 2004) . Proportionally, these cancers are most prominent among adults from 45 to 64 years old and represent the primary form of cancer among men aged under 55 years worldwide.
Though there has been some limited progress in the treatment, there seems to be a better potential for primary prevention. The latter focuses on identifying lifestyle, behavioral, or other causes of UADT cancersmainly alcohol intake and tobacco smoking, but also social factors and human papilloma virus infection -potential protective factors, notably dietary, as well as possible interactions of exogenous causes with genetic susceptibility.
In 2007, an International Agency for Research on Cancer (IARC) Monographs Working Group reviewed the evidence on the possible association between alcohol consumption and cancer at 27 anatomical sites. Their conclusions will be published in Volume 96 of the IARC Monographs (IARC, 2007) . For cancers of the UADT the panel concluded that 'regular alcohol consumption is associated with an increased risk for cancers of the oral cavity, pharynx, larynx, and the esophagus. Daily consumption of around 50 g of ethanol increases the risk for these cancers two to three times, compared with the risk in nondrinkers'. Similar conclusions were reached in the 2007 World Cancer Research Fund report (World Cancer Research Fund/American Institute for Cancer Research, 2007) . UADT cancers are also convincingly related to tobacco smoking (IARC, 2004) and the combined effects of drinking and smoking seem to be multiplicative (IARC, 2007) . Moreover, there is evidence of a probable inverse association of these cancers with intake of nonstarchy vegetables and fruits (World Cancer Research Fund/American Institute for Cancer Research, 2007) . With respect to genetic susceptibility to UADT cancers, several genes involved in metabolizing alcohol and tobacco-related carcinogens are prime candidates. These include the families of alcohol dehydrogenase and acetaldehyde dehydrogenase genes.
In 2002, the IARC initiated the alcohol-related cancers and genetic susceptibility in Europe (ARCAGE) project with the participation of 15 centers in 11 European countries, namely, Zagreb (Croatia), Prague (Czech Republic), Tartu (Estonia), Paris (France), Bremen (Germany), Athens (Greece), Dublin (Ireland), Aviano, Padova and Turin (Italy), Oslo (Norway), Barcelona (Spain) and Glasgow, Manchester and Newcastle (UK). The specific aims of the study were to (i) investigate whether specific patterns and types of known etiological factors are particularly important, including specific type of alcohol consumption and patterns of drinking; (ii) study the role of dietary components and patterns with a focus on fruit and fresh vegetables as potentially protective, and pickled vegetables and meat as potentially detrimental; (iii) examine the interaction between high alcohol intake and dietary or other lifestyle factors, especially low consumption of fruits and vegetables, and tobacco consumption; (iv) investigate the role of genetic susceptibility to alcohol and tobacco metabolism and DNA damage in determining individual risk for UADT cancers; (v) investigate the role of human papilloma virus infection on UADT cancer risk; and (vi) undertake genome-wide association studies to identify genes related to UADT cancer risk.
Methods

Study design and ethical issues
ARCAGE was designed as a multicenter case-control study. In the French center, recruitment was already completed at the launch of the ARCAGE study, but the inclusion of cases, controls and their biological samples was deemed beneficial for the overall ARCAGE objective. Differences in the study design and selection criteria for cases and controls between the French and the other ARCAGE centers (in France the study included only smokers, was restricted to squamous cell carcinomas and did not recruit esophageal cancer cases) will be accounted for in publications focusing on specific genetic and exogenous exposures. ARCAGE was approved by the Ethical Review Board of IARC, as well as the respective local boards in the individual participating centers. All participants provided written informed consent for their participation in the study.
Definition and recruitment of cases
Cases were identified from the participating hospitals, as soon as possible after the diagnosis was made and as a rule within 6 months of diagnosis. In the presence of a strong clinical suspicion, a case was interviewed and biological samples were taken, pending subsequent confirmation. Early identification was achieved through active search, that is, by means of periodical visits to the hospital departments where cases were diagnosed or treated (i.e. ear-nose-throat, gastroenterology, oncology, surgery, radiotherapy, and pathology departments). The frequency of the visits (daily, weekly, etc.) depended on the inflow of cancer patients in each clinical department. A case could be included even if treatment was initiated before recruitment; in such circumstances details on the treatment given and the duration of the treatment were recorded. Cases included in the study were histologically or cytologically confirmed and information on topography and histological type of the tumors was collected. A case could not be counted twice, even if the patient presented with two primary tumors within the period of recruitment.
Cases eligible for inclusion in the study were those classified under the following International Classification of Diseases for Oncology (ICD-O) codes (Percy et al., 1990) : C00 Lip (excluding C00.0, C00.1, and C00.2, i.e. external, upper, lower, and not otherwise specified lip); C01 Base of tongue; C02 Other and unspecified parts of the tongue; C03 Gum; C04 Floor of mouth; C05 Palate; C06 Other and unspecified parts of the mouth; C09 Tonsil; C10 Oropharynx; C12 Pyriform sinus; C13 Hypopharynx; C14.0 Pharynx, wall of pharynx, lateral wall of pharynx, posterior wall of pharynx, retropharynx, throat (all these sites non-otherwise specified); C14. of oesophagus; C15.8 Overlapping lesion of oesophagus; C15.9 oesophagus unspecified; and C32 Larynx. Neoplasms were assigned to the subcategory that included the apparent point of origin of the tumor. Data on C07 (Parotid gland) and C08 (Other and unspecified major salivary glands) cancer cases were also recorded in a separate database for future analyses.
Selection and recruitment of controls
In each center, controls were frequency matched to cases by sex, age (in 5-year groups), and referral (or residence) area. ARCAGE centers mainly used hospital controls, to facilitate collection of blood samples; in the UK centers, however, population controls were randomly chosen from the same family medical practice list as the corresponding cases. Specifically, for each case, a total of 10 controls were selected from the same family medical practice, matched by age and sex. The potential controls were approached in random order and, in case of nonparticipation of the first potential control, the second one was approached and so on until one agreed to participate.
Hospital controls were randomly chosen among subjects admitted as inpatients or outpatients to the same hospital as the cases. As the catchment area of some tertiary care hospitals could differ between cases and controls, residence restrictions had to be applied in some centers. Only controls with a recently diagnosed disease were accepted; most controls were patients who had been in the hospital for less than 1 week, to avoid oversampling of long stay patients. Admission diagnoses related to alcohol, tobacco, or dietary practices were excluded. Eligible control admission diagnoses included (i) endocrine and metabolic; (ii) genitourinary; (iii) skin, subcutaneous tissue, and musculoskeletal; (iv) gastro-intestinal; (v) circulatory; (vi) ear, eye; and mastoid; and (vii) nervous system diseases; as well as (viii) plastic surgery cases; and (ix) trauma patients. The proportion of controls within a specific diagnostic group was not to exceed 33% of the total.
Lifestyle questionnaire
Cases and controls underwent identical interviews during which they completed a lifestyle questionnaire. The questionnaire collected information on the following: 1. Socio-demographic details (age/sex/residence/education). 2. Detailed smoking history, including cigarette, cigar, and pipe smoking. 3. Exposure to environmental tobacco smoke for neversmokers only. 4. Dietary habits, based on a semiquantitative food frequency questionnaire and recording the frequency of consumption of 22 food items or groups, and information on coffee and tea consumption and the temperature at which these beverages were consumed. In the Athens center, an extensive semiquantitative food frequency questionnaire was used and the information was subsequently condensed to the ARCAGE basic diet questionnaire. The dietary variables in the French center overlapped with those of the ARCAGE basic diet questionnaire, but were not identical. 5. Complete history of alcohol drinking, including types of alcoholic drinks and patterns of drinking (e.g. timing during the day, with or without meals). In the Dublin, Glasgow, Manchester, and Newcastle centers, show cards helped quantify the size of drink and consumption was expressed in units of 10 ml ethanol.
In all other centers, number of specific alcoholic drinks with defined volume was recorded. 6. History of various diseases, with emphasis on fungal, human papilloma, and herpes virus-related conditions, as well as reflux symptoms. 7. Oral cavity health. 8. Lifetime occupational history, with information on both job title and description of tasks.
Education, beverage temperature, exposure to environmental tobacco smoke, history of various diseases, and oral cavity health were not recorded at the French center.
Centers translated the questionnaire into the local language and organized training courses for the interviewers before the initiation of interviews. These courses were based on a common training procedure developed by IARC. Training for the interview concentrated on assuring comparability and maximizing completeness and accuracy. Interviewers were encouraged to minimize the extent of missing data by probing responses to ensure that the answers received were clear and correct. These aspects of interviewing were introduced to the interviewer during pilot interviews, which were conducted in the feasibility stage of the study.
Anthropometry
In all but the UK and the Dublin centers, interviewers were also trained to make anthropometric measures and if those were not feasible to collect the relevant information from medical records or to ask the study participants themselves. In addition to weight and height at recruitment, weight 2 years before the interview, as well as weight at the age 30 years (when applicable), were also recorded except in the French center.
Biological sample collection
Blood samples were obtained at the time of interview unless a more convenient time was identified. When feasible, two 10-ml samples of blood were collected. A portion of the blood was centrifuged for 10 min at 2000 rpm and white blood cells, red blood cells, and plasma were obtained. All samples were stored locally at -801C (or at least -701C depending on type of freezer).
The amount of time between sample collection and freezing did not exceed 12 h.
When possible, fresh tumor tissue was obtained from the cases. If fresh samples were obtained during biopsy or surgery they were snap frozen, when possible, and stored at -801C within 20 min of being taken. Whether the tumor tissue samples were snap frozen or not was recorded on the logsheet. Investigators also consulted with local pathologists on the availability of paraffin-embedded tissue or diagnostic slides from cases. When feasible, either a full block, part of a block, or shavings from a block were obtained. Shavings were required to be at least 10 mm thick. Histological, as well as all immunohistochemistry reports from the local pathologists were also collected.
Standardized color-coded cryotubes were used to facilitate identification of different types of biosamples for each participant. The printed identification labels were provided by IARC and were placed on all tubes containing biological samples.
At least 50% of samples from all cases and controls were transferred -in cardboard boxes with a polystyrene lining, containing a sufficient quantity of dry ice (solid CO 2 ) -to the central laboratory at IARC, for central storage in nitrogen vapor ( -1201C). Extraction of DNA was done at IARC using an automated robot.
Genotyping An initial review of potential genes associated with UADT cancers was conducted in 2002 to identify genes with some preliminary data indicating an association with UADT cancers, or genes which could have an association on the basis of their presumed biological function (Gemignani et al., 2002; Landi et al., 2003) and gene expression data (Al Moustafa et al., 2002) . In addition, searches of Medline using keywords such as 'genetic', 'susceptibility', and 'cancer' were performed. This review resulted in a list of 92 genes involved in metabolism of alcohol and tobacco, DNA repair, cell-cycle control, apoptosis and addiction, which were considered to be the most likely candidates for affecting susceptibility to tobacco or alcohol-related cancers.
A review of the literature concerning polymorphisms of the selected genes was carried out using as a starting point the polymorphisms published by Gemignani et al. It was not deemed necessary to include all selected SNPs, as many would be rare or not provide useful information. For the final analysis, it was decided to include any SNP that satisfied at least one of the following criteria: (i) SNP with allele frequency greater than 5% in Caucasians; (ii) SNP with an earlier reported association for lung or UADT cancer (P < 0.05); (iii) SNP with low or unknown allele frequency in Caucasians, but with high allele frequency in non-Caucasians ( > 25%); (iv) SNPs in coding regions were preferred to the ones in the noncoding regions; (v) the distribution of the SNPs within a gene was required not to cluster too close; and (vi) SNPs passed the PCR and arrayed primer extension primer design with the highest rank. These selection criteria resulted in a final group of 166 SNPs from the 76 genes to be included on the CHIP.
Genotyping was conducted using the Arrayed Primer Extension method Tõnisson et al., 2000) . Signal detection and interpretation was performed by Genorama imaging and analysis software (Asper Biotech Ltd., Tartu, Estonia; http://www.asperbio.com).
For the ARCAGE-CHIP validation, 125 anonymous DNA samples (some of them in duplicate) from the SNP500 collection, also known as Coriell samples, were genotyped. The samples from the SNP500 collection include subjects from the main ethnic groups represented in the United States, with a subset of Centre d'Etude du Polymorphisme Humain families. The genotype data from these samples generated by bidirectional sequencing has been made publicly available on the website (http://snp500cancer.nci.nih.gov). In the first step, 40 anonymous human DNA samples from the SNP500 collection were genotyped for the selected 166 SNPs. One hundred and thirty-two SNPs yielded a call rate greater than 0.97 and concordance with the SNP500 database greater than 0.97, suitable for future robust genotyping for thousands of control and patient samples. In the second step of the CHIP validation, 72 new SNPs were added to the CHIP (see selection criteria above) and genotyped on the rest of the 85 SNP500 collection samples. The new set of SNPs was selected from (i) the relevant genes when at least two to three SNPs per gene were available, and (ii) genes added to the initial list on the basis of information from the literature and databases that became available after the initiation of ARCAGE. After evaluation, 166 SNPs were selected for further large-scale genotyping.
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Results
Recruitment was conducted from 2002 to 2005 in all centers but the French one, where it was conducted from 1987 to 1992. A total of 3061 case patients and 3571 control subjects were contacted for the study. Reasons for nonparticipation among cases were: unavailability for interview because of illness, language or incorrect contact information (n = 101), physician refusal (n = 48), case deceased (n = 68), scheduling conflicts (n = 9), and unspecified (n = 335). Among controls (both hospital and population-based), reasons for nonparticipation included: unavailability for interview because of illness, language or incorrect contact information (n = 24), physician refusal (n = 36), control deceased (n = 3), scheduling conflicts (n = 47), and unspecified (n = 1049). The participation proportion is overestimated in centers in which nonparticipating cases and controls explicitly refused any recording of their information. A total of 2500 cases and 2412 controls completed the interview with the questionnaire (Table 1) .
Of the cases who completed the interview the following were excluded: 81 cases because the final diagnosis revealed tumors that were not categorized in the ICD-O codes listed in the protocol, 40 cases because they had insitu carcinomas, or tumors of either uncertain nature (benign or malignant) or uncertain origin (primary or metastatic), 31 cases who were designated as prevalent, five cases because of ethnicity (very few for independent analysis), and one case because the patient was interviewed twice. An additional four cases were eventually not diagnosed with cancer and they were included among the controls. Finally, 34 cases with salivary gland cancers were excluded because the etiologic pattern of these cancers differs from that of other UADT cancers (Sun et al., 1999) . Of the 2416 controls who completed the interviews (2412 and the four cases who changed status and were listed as controls) the following were excluded: 153 because their admission diagnosis could reflect a preneoplastic condition, or was considered to be related to diet, alcohol drinking, or smoking, 25 because they were diagnosed with cancer, seven because of ethnicity, two because genotyping revealed that they were siblings of other participants, and two because they were interviewed twice. Eventually, 2304 cases and 2227 controls were included in the final dataset (Table 1) . In Table 2 the distribution of cases and controls by sex and age group is presented. As expected, male UADT cancer patients were four times as numerous as female patients. Fewer than 20% of cases were diagnosed before the age of 50 years. As in some instances contacted cases and controls explicitly refused any recording of information, participation proportions can be overestimated. The proportions presented are based on the information recorded in the nonresponders database. b
In the UK centers population controls were used. The Tartu, Estonia center was responsible for the genotyping and did not recruit cases and controls.
histological type and subsite. With respect to histology, as expected, more than 90% of cases refer to squamous cell carcinomas. The distribution of cancer cases by subsite in the ARCAGE centers reflects the case mix in the participating hospital(s) and cannot be used to ascertain proportional distributions in the underlying populations. Of the 2304 cases, 702 refer to laryngeal cancer, 534 to cancer of the oral cavity, 505 to cancer of the oropharynx, 235 to cancer of the esophagus, and 196 to cancer of the hypopharynx.
Tables 4 and 5 show crude distributions of cases and controls by center and sex with respect to tobacco smoking (never, former, current) and alcohol drinking habits (never and ever drinkers). A clear preponderance of smokers and alcohol drinkers among UADT cases compared with controls was observed. Controlling for center and sex only, the odds ratio (OR) for former versus never smokers is 2.53 with 95% confidence interval (CI) 2.08-3.08, whereas for current versus never smokers the corresponding OR is 7.39 (95% CI, 6.14-8.91). With respect to alcohol drinking and, again, controlling only for center and sex, the OR for ever versus never drinkers is 2.23 (95% CI, 1.77-2.81).
Discussion
ARCAGE is one of the largest epidemiological investigations of cancer of the UADT ever undertaken, and was based on a common protocol developed at IARC with the input of investigators from 15 participating centers in 11 European countries. The objective of ARCAGE is to probe the etiology of UADT cancers, with emphasis on factors that are considered as established or likely causes of this group of cancers, notably consumption of alcoholic beverages of various types, tobacco smoking, reduced intake of fresh fruits and vegetables, and increased intake of salted and preserved foods. Assessment of the role of genetic susceptibility to UADT cancers and possible interaction of genetic factors with the indicated lifestyle and environmental factors, however, is the central objective of ARCAGE.
Although attribution of a certain fraction of cancer cases or deaths to a particular exposure or genetic determinant is an appealing and popular practice, it does not have a sound methodological basis (the role of, say, diet is proportionally more important in a population of nonsmokers and nondrinkers than among smokers and drinkers). In fact, it is the fraction of the variance of UADT incidence or mortality that can be explained by specific factors, for example, diet or smoking or genetic predisposition, that conveys a better insight into the relative importance of the various risk factors. Within Europe, incidence of UADT cancers, overall and by specific site, varies substantially, with countries at the extremes having three-fold differences (Ferlay et al., 2004) . Neither absolute levels of alcohol consumption nor tobacco smoking can adequately explain this variability. ARCAGE aims to explore whether genetic modulation of ethanol or tobacco metabolism, genetic variation in DNA repair, or interactions among lifestyle factors or between For one female and four male cases and for two female and one male control, information on age was missing. For one control, information on sex was missing. 287  276  11  0  55  98  41  6  76  11  0  Athens  244  214  30  0  51  19  2  37  113  22  0  Aviano  152  146  6  0  49  35  11  1  37  19  0  Padova  135  126  9  0  26  27  14  0  51  17  0  Turin  167  152  15  0  66  29  10  2  42  17  1  Dublin  44  33  11  0  8  6  5  0  5  20  0  Oslo  173  135  37  1  44  53  12  2  32  30  0  Glasgow  98  95  3  0  17  23  9  25  19  1  4  Manchester  151  142  9  0  66  43  9  12  21  0  0  Newcastle  89  68  13  8  19  9  4  10  23  24  0  Barcelona  195  183  12  0  47  35  17  3  83  10  0  Zagreb  54  50  1  3  31  13  8  0  2  0  0  Paris a  323  323  0  0  49  62  40  18  154  0  0  Total  2304  2109  183  12  534  505  196  125  702  235 ARCAGE was designed as a case-control study. As Clayton and McKeigue (2001) have pointed out, in comparison with the cohort design, the case-control design maximizes statistical power and is quicker and cheaper for study of associations between genotype and risk of disease.
The main disadvantage of case-control studies, that is, susceptibility to bias when estimating effects of exposures that are measured retrospectively, does not generally apply when studying statistical interaction between genotype and environmental exposures.
ARCAGE relies on histologically confirmed cases, categorized under specific ICD-O codes. With respect to source of controls, the study group carefully considered the advantages and disadvantages of the two main sources, hospital and population controls. Population controls are theoretically preferable, but they often suffer from lower response rates and differential recall from the cases. Hospital controls have the advantage of convenience and high participation rates and recall of past lifestyle habits in a way usually similar to that of the cases. ARCAGE relies on hospital controls in all but the UK centers, in which recruitment of population controls through General Medical Practice lists was feasible. The main inclusion criterion for the controls was that their admission diagnosis should not be a condition related to tobacco smoking, alcohol intake, or diet, so that selection bias would be minimized. In the final ARCAGE dataset, a total of 2304 cases of UADT cancers and 2227 controls were included, although in specific exposure and outcome analyses, fewer cases and controls may be included, depending on missing values.
Tobacco smoking and alcohol drinking are established causes of UADT cancers, but the role of particular patterns of smoking and drinking remains to be elucidated and will be examined in detail in future ARCAGE publications. Nevertheless, the crude results presented here with respect to these major lifestyle risk factors serve to document the validity and the statistical power of the ARCAGE project, as the relevant results are in line with the collective epidemiological evidence (IARC, 2004 (IARC, , 2007 World Cancer Research Fund/American Institute for Cancer Research, 2007) .
As indicated, the main focus of ARCAGE is the identification, through a genetic association investigation, of genetic polymorphisms that could be involved in the etiology of UADT cancers on account of their role in the metabolism of ethanol and tobacco smoke, or their effects on DNA repair. Genetic association studies require large sample sizes, particularly if interactions with nongenetic factors are to be examined. Indeed, one of the few welldocumented interactions between a genetic polymorphism and a dietary factor in the etiology of lung cancer relied on a total number of cases and controls of a similar order of magnitude to those included in ARCAGE (Brennan et al., 2005) .
In conclusion, ARCAGE is a large multicenter casecontrol investigation. It represents a major collaborative effort, coordinated by IARC, to identify and quantify the contribution of genetic and environmental factors in the etiology of UADT cancers in Europe. Participation proportions were satisfactory for both cases and controls and, although the source of the latter group was not identical across the participating centers, this will be exploited for the assessment of the consistency of the results among centers. The multicenter nature of the project ensures wide range of environmental exposures and adequate genetic variability, as well as representation of the relevant patterns across Europe. 
